ReviewFrontiers in endocrinology2022
Feasibility analysis of incorporating infertility into medical insurance in China.
Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Assessing the efficacy of varicocelectomy, antioxidants, FSH treatment, and lifestyle modifications on sperm DNA fragmentation: a systematic review and meta-analysis.Scientific reports · 2025Pooled it
- Feasibility analysis of China's medical insurance coverage of assisted reproductive technology.Scientific reports · 2024Pooled it
- Protocol for a multicentre survey of sexual and reproductive health and fertility among unmarried women living in China's megacities.BMJ open · 2026Article
- Development and validation of a nomogram for predicting the risk of threatened abortion after in vitro fertilization-embryo transfer.Pakistan journal of medical sciences · 2026Article
- Cross-cultural adaptation and validation of the ENRICh scale for Chinese infertile patients: a methodological and cross-sectional study.BMC public health · 2025Article
- Healthcare providers' perceptions on facility-based screening for intimate partner violence: a multi-center qualitative formative research at assisted reproductive technology clinics.BMC health services research · 2025Article
- Willingness to pay for assisted reproductive technologies among individuals with infertility in China.Health policy and planning · 2025Article
- Health insurance integration and fertility intentions among migrant populations in China: evidence from urban-rural medical reform.BMC health services research · 2025Article
- Review
- Research on the perception of pre-semen collection stress and its influencing factors in men on the day of oocyte retrieval in IVF-ET.Journal of assisted reproduction and genetics · 2025Article
- Perceptions of Health System Professionals on Integrating Fertility Care into Reproductive Health Policy in China.Healthcare (Basel, Switzerland) · 2025Article
- Separate and cumulative effect of risk and protective factors associated with suicidal ideation among Chinese infertile couples: a cross-sectional study.Frontiers in psychology · 2025Article
- Endometriosis-related infertility in China: analysis of the global burden of disease study 2021.Frontiers in public health · 2025Article
- Research Progress of Ribosomal Proteins in Reproductive Development.International journal of molecular sciences · 2024Review
- Intimate partner violence in the context of infertility: voices from women seeking assisted reproductive technology treatment and clinicians' perspectives.Reproductive health · 2024Article
- Article
- The Impact of Follicular Fluid Oxidative Stress Levels on the Outcomes of Assisted Reproductive Therapy.Antioxidants (Basel, Switzerland) · 2023Review
- Association of living environmental and occupational factors with semen quality in chinese men: a cross-sectional study.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the incidence of infertility has been increasing gradually, while the natural rate of population growth is declining or even at zero growth. China is observed to enter a depth of aging society, leading to more severe infertility. Infertility patients face many predicaments, and many unreasonable behaviors existed in seeking medical diagnosis and treatment, of which the main influencing factor is economic condition. In China, Beijing has taken the lead in providing medical insurance for 16 assisted reproductive technology items. Assuming that all infertile couples with the option of assisted reproduction are treated, there would be a huge market gap. The reimbursement rate can be adjusted based on some factors within the affordable range of the medical insurance fund. Progress on infertility coverage in other countries was also reviewed. This paper cited the data of medical insurance funds in China in the recent 4 years as a reference. Based on the data, it is not currently able to cover all the costs of infertility diagnosis and treatment during the research period, but it is feasible to access selective reimbursement and subsidies for those in particular need as well as to develop some commercial insurances. There is a big gap in the application of assisted reproductive technology between China and developed countries. More comprehensive and constructive policies should be formulated countrywide to standardize the market. Assisted reproduction-related technologies and acceleration of the domestic medical apparatus and instrument replacement should be improved to reduce the cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.